No Data
No Data
Trending Stocks Today: NANO Nuclear Energy Inches up 8.83% Post-Market
June 28th - US stocks trending post-market.Gainers: $NANO Nuclear Energy(NNE.US)$ climbs 8.83% to $25.51 with a turnover of $5.29 million. $Ginkgo Bioworks(DNA.US)$ up 3.2% to $0.35 with a turnover of
Sector Update: Health Care Stocks Steady Premarket Friday
Health care stocks were steady premarket Friday with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) inactive recently. Sarepta Therapeutics (SRPT) rallie
Ocugen's Receives Nod to Enrol in High Dose Study of Stargardt Disease Drug Candidate
Ocugen (OCGN) said Friday that the Data and Safety Monitoring Board approved proceeding with the high dose of its experimental drug OCU410ST to treat Stargardt disease, a rare eye disease, in the dose
Express News | Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
• Established Medium Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial• DSMB Determination to Proceed with High Dose Cohort DosingMALVERN, Pa., June 21, 2024 (GLOBE NEWSWIRE) -- O
Express News | Ocugen Shares Are Trading Lower. The Company Announced That the First Patient Has Been Dosed in Its Phase 3 LiMeliGhT Clinical Trial for OCU400—a Modifier Gene Therapy Product Candidate Being Developed for Retinitis Pigmentosa
No Data